Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 15;12(4):e047309.
doi: 10.1136/bmjopen-2020-047309.

Lessons learned from the COVID-19 pandemic about sample access for research in the UK

Jessica M Sims  1 , Emma Lawrence  1 , Katy Glazer  1 , Amir Gander  1 , Barry Fuller  1 , Brian R Davidson  1   2 , Jonathan Garibaldi  3 , Philip R Quinlan  4
Affiliations
Review

Lessons learned from the COVID-19 pandemic about sample access for research in the UK

Jessica M Sims et al. BMJ Open. .

Abstract

Objective: Annotated clinical samples taken from patients are a foundation of translational medical research and give mechanistic insight into drug trials. Prior research by the Tissue Directory and Coordination Centre (TDCC) indicated that researchers, particularly those in industry, face many barriers in accessing patient samples. The arrival of the COVID-19 pandemic to the UK produced an immediate and extreme shockwave, which impacted on the ability to undertake all crucial translational research. As a national coordination centre, the TDCC is tasked with improving efficiency in the biobanking sector. Thus, we took responsibility to identify and coordinate UK tissue sample collection organisations (biobanks) able to collect COVID-19-related samples for researchers between March and September 2020.

Findings: Almost a third of UK biobanks were closed during the first wave of the UK COVID-19 pandemic. Of the remainder, 43% had limited capabilities while 26% maintained normal activity. Of the nationally prioritised COVID-19 interventional studies, just three of the five that responded to questioning were collecting human samples. Of the 41 requests for COVID-19 samples received by the TDCC, only four could be fulfilled due to a lack of UK coordinated strategy. Meanwhile, in the background there are numerous reports that sample collections in the UK remain largely underutilised.

Conclusion: The response to a pandemic demands high level co-ordinated research responses to reduce mortality. Our study highlights the lack of efficiency and coordination between human sample collections and clinical trials across the UK. UK sample access is not working for researchers, clinicians or patients. A radical change is required in the strategy for sample collection and distribution to maximise this valuable resource of human-donated samples.

Keywords: COVID-19; ethics (see Medical Ethics); health informatics; health policy.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Status of tissue banks in the UK during COVID-19 pandemic (March–September 2020).
See this image and copyright information in PMC

References

    1. Lawrence E, Sims J, Gander A, et al. . The barriers and motivators to using human tissues for research: the views of UK-based biomedical researchers. Biopreserv Biobank 2020;18:266–73. 10.1089/bio.2019.0138 - DOI - PMC - PubMed
    1. The BioIndustry Association and The Medicines Discovery Catapult . State of the discovery nation 2019, 2019.
    1. Quinlan PR, Lawrence E, Pourabdolla A, et al. . The UK Clinical Research Collaboration (UKCRC) Tissue Directory and Coordination Centre: The UK’s Centre for facilitating the Usage of Human Samples for Medical Research. Open J Bioresour 2017;4. 10.5334/ojb.31 - DOI
    1. Quinlan P. UKCRC tissue directory, 2016. Available: https://www.biobankinguk.org/directory/ [Accessed 14 Dec 2020].
    1. Sample I. Blood sample shortage holding up UK work on antibody tests, in The Guardian. The Guardian 2020.

Publication types